Anagrelide HCl
Anagrelide hydrochloride, also known as Agrylin, is a drug used for the treatment of essential thrombocytosis---overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia. Anagrelide controlled release (GALE-401) is in phase III clinical trials by Galena Biopharma for the treatment of essential thrombocytosis.
Product Specifications
CAS Number
58579-51-4
Product Name Alternative
Anagrelide hydrochloride | BL 4162A | GALE-401 | Thromboreductin
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO : 7.69 mg/mL 26.29 mM; H2O : < 0.1 mg/mL
Smiles
Cl.ClC1=CC=C2NC3=NC (=O) CN3CC2=C1Cl
Molecular Formula
C10H7Cl2N3O·HCl
Molecular Weight
292.55
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Imidazo (2,1-b) quinazolin-2 (3H) -one, 6,7-dichloro-1,5-dihydro-, monohydrochloride
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Rabbit anti-Drosophila melanogaster (Fruit fly) EbpII Polyclonal Antibody
Interleukin 1 Receptor Antagonist (IL1RA, IL1RN, IL1-RA, ICIL1RA, IL1ra3, IL1F3, IRAP, IL-1RA, Interleukin-1 Family Member 3)
